Design, synthesis, structure-activity relationship, and in vivo activity of azabicyclic aryl amides as alpha7 nicotinic acetylcholine receptor agonists.
暂无分享,去创建一个
Brandon J. Margolis | Mihaly Hajos | Thomas J. Raub | E. Wong | R. Hurst | M. Hajós | Daniel P. Walker | L. Cortes-Burgos | W. E. Hoffmann | R. R. Walters | Daniel P Walker | T. Vetman | Paula M Tinholt | S. Jia | D. Wishka | D. W. Piotrowski | S. C. Reitz | K. Yates | J. Myers | E. Jacobsen | Brad A. Acker | V. Groppi | M. Wolfe | B. Thornburgh | M. Hester | E. Seest | L. Dolak | Fusen Han | Barbara A Olson | Laura R Fitzgerald | B. Staton | Kai S Li | N. Higdon | T. Wall | Bruce N. Rogers | David W Piotrowski | Thomas J Raub | Brian A Staton | Bruce N Rogers | William E Hoffmann | Raymond S Hurst | Donn G Wishka | Shaojuan Jia | Steven C Reitz | Karen M Yates | Jason K Myers | Tatiana N Vetman | Brandon J Margolis | E Jon Jacobsen | Brad A Acker | Vincent E Groppi | Mark L Wolfe | Bruce A Thornburgh | Luz A Cortes-Burgos | Rodney R Walters | Matthew R Hester | Eric P Seest | Lester A Dolak | Fusen Han | Laura Fitzgerald | Kai S Li | Nicole R Higdon | Theron M Wall | Erik H F Wong | D. Piotrowski
[1] M. Hajós. Targeting information-processing deficit in schizophrenia: a novel approach to psychotherapeutic drug discovery. , 2006, Trends in pharmacological sciences.
[2] P. J. Bouchard,et al. Disubstituted Indazoles as Potent Antagonists of the Integrin αvβ3 , 2000 .
[3] D. Donnelly-roberts,et al. Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors. , 1998, Science.
[4] D. Bertrand,et al. Neuronal nicotinic acetylcholine receptors: from the gene to the disease , 2000, Behavioural Brain Research.
[5] Thomas J. Raub,et al. In vitro models of the blood-brain barrier. , 1998, Alternatives to laboratory animals : ATLA.
[6] W. C. Still,et al. Rapid chromatographic technique for preparative separations with moderate resolution , 1978 .
[7] R. Papke,et al. 3-[2,4-Dimethoxybenzylidene]anabaseine (DMXB) selectively activates rat α7 receptors and improves memory-related behaviors in a mecamylamine-sensitive manner , 1997, Brain Research.
[8] J. Meltzer,et al. Nicotinic cholinergic normalization of amphetamine-induced loss of auditory gating in freely moving rats , 1995, Psychopharmacology.
[9] R. Myers,et al. Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel. , 1991, Science.
[10] G. Szakács,et al. Functional Multidrug Resistance Protein (MRP1) Lacking the N-terminal Transmembrane Domain* , 1998, The Journal of Biological Chemistry.
[11] G. Spalluto,et al. A new approach to kainoids through tandem Michael reaction methodology: application to the enantioselective synthesis of (+)- and (-)-.alpha.-allokainic acid and to the formal synthesis of (-)-.alpha.-kainic acid , 1992 .
[12] R. Papke,et al. Characterization of a series of anabaseine-derived compounds reveals that the 3-(4)-dimethylaminocinnamylidine derivative is a selective agonist at neuronal nicotinic alpha 7/125I-alpha-bungarotoxin receptor subtypes. , 1995, Molecular pharmacology.
[13] J. A. Dani,et al. Overview of nicotinic receptors and their roles in the central nervous system , 2001, Biological Psychiatry.
[14] Larry Miller,et al. Separation of a racemic pharmaceutical intermediate using closed-loop steady state recycling , 1998 .
[15] J. Daly. Nicotinic Agonists, Antagonists, and Modulators From Natural Sources , 2005, Cellular and Molecular Neurobiology.
[16] C. Swain,et al. Novel 5-HT3 antagonists: indol-3-ylspiro(azabicycloalkane-3,5'(4'H)-oxazoles). , 1992, Journal of medicinal chemistry.
[17] J S Ward,et al. Functionally selective M1 muscarinic agonists. 3. Side chains and azacycles contributing to functional muscarinic selectivity among pyrazinylazacycles. , 1995, Journal of medicinal chemistry.
[18] J. Macor,et al. (-)-Spiro[1-azabicyclo[2.2.2]octane-3,5'-oxazolidin-2'-one], a conformationally restricted analogue of acetylcholine, is a highly selective full agonist at the alpha 7 nicotinic acetylcholine receptor. , 2000, Journal of medicinal chemistry.
[19] A. Mazurov,et al. Selective α7 Nicotinic Acetylcholine Receptor Ligands , 2006 .
[20] M. Langlois,et al. N-chloromethyl quinuclidinium derivatives: A new class of irreversible ligands for 5-HT3 receptors. , 1994 .
[21] K. Seio,et al. (+)-3-[2-(Benzo[b]thiophen-2-yl)-2-oxoethyl]-1-azabicyclo[2.2.2]octane as potent agonists for the alpha7 nicotinic acetylcholine receptor. , 2004, Bioorganic & medicinal chemistry letters.
[22] D. Mckenna,et al. Human α 7 nicotinic acetylcholine receptor responses to novel ligands , 1995, Neuropharmacology.
[23] S. Viskin. Long QT syndromes and torsade de pointes , 1999, The Lancet.
[24] P. Potier,et al. A practical synthesis of 1H-pyrrolo[2,3-c]pyridine-5-carboxylic acid derivatives from pyrrole-2-carboxaldehydes , 1993 .
[25] J. Changeux,et al. Chimaeric nicotinic–serotonergic receptor combines distinct ligand binding and channel specificities , 1993, Nature.
[26] L. Munoz,et al. Synthesis and evaluation of phenylcarbamate derivatives as ligands for nicotinic acetylcholine receptors. , 2004, Bioorganic & medicinal chemistry.
[27] S. Ng,et al. Synthesis and biological evaluation of 2-indolyloxazolines as a new class of tubulin polymerization inhibitors. Discovery of A-289099 as an orally active antitumor agent. , 2002, Bioorganic & medicinal chemistry letters.
[28] L. Pannell,et al. Epibatidine: a novel (chloropyridyl)azabicycloheptane with potent analgesic activity from an ecuadoran poison frog , 1992 .
[29] E. Levin,et al. Nicotinic acetylcholine involvement in cognitive function in animals , 1998, Psychopharmacology.
[30] J K Lynch,et al. Neuronal nicotinic acetylcholine receptors as targets for drug discovery. , 1997, Journal of medicinal chemistry.
[31] John Saunders,et al. Ester bio-isosteres: synthesis of oxadiazolyl-1-azabicyclo[2.2.1]heptanes as muscarinic agonists , 1988 .
[32] J. Vaquero,et al. Pyrrolodiazines. 5. Synthesis, Structure, and Chemistry of Pyrrolo[1,2-c]pyrimidine. Dipolar Cycloaddition of Pyrrolo[1,2-c]pyrimidinium Ylides , 1999 .
[33] J. Schmitt,et al. Exploring the nature of molecular recognition in nicotinic acetylcholine receptors. , 2000, Current medicinal chemistry.
[34] J. Patrick,et al. Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[35] M. Romanelli,et al. Cholinergic nicotinic receptors: Competitive ligands, allosteric modulators, and their potential applications , 2003, Medicinal research reviews.
[36] A. Meyers,et al. Total Synthesis of Bistratamide D. , 1999, The Journal of organic chemistry.
[37] Michael Krause,et al. Auditory sensory gating in hippocampus and reticular thalamic neurons in anesthetized rats , 2003, Biological Psychiatry.
[38] C. Gotti,et al. Neuronal nicotinic receptors, important new players in brain function. , 2000, European journal of pharmacology.
[39] L. A. Carpino. 1-Hydroxy-7-azabenzotriazole. An efficient peptide coupling additive , 1993 .
[40] Brian T. O’Neill,et al. Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation , 2005 .
[41] G. Paxinos,et al. The Rat Brain in Stereotaxic Coordinates , 1983 .
[42] S. Arneric,et al. Neuronal nicotinic receptors : pharmacology and therapeutic opportunities , 1999 .
[43] Thomas J. Raub,et al. Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure--activity relationship. , 2006, Journal of medicinal chemistry.
[44] G. Spalluto,et al. Tandem michael reactions for the construction of pyrrolidine and piperidine ring systems , 1990 .
[45] Gregory J Brewer,et al. Isolation and culture of adult rat hippocampal neurons , 1997, Journal of Neuroscience Methods.
[46] M. Trudell,et al. A Short and Efficient Total Synthesis of (+/-)-Epibatidine. , 1996, The Journal of organic chemistry.
[47] Jun Chen,et al. A structural basis for drug-induced long QT syndrome. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[48] J. Boot,et al. Recent progress in the development of subtype selective nicotinic acetylcholine receptor ligands. , 2002, Current drug targets. CNS and neurological disorders.
[49] C. L. Shaffer,et al. Using a Tritiated Compound to Elucidate Its Preclinical Metabolic and Excretory Pathways in Vivo: Exploring Tritium Exchange Risk , 2006, Drug Metabolism and Disposition.
[50] E. Wong,et al. Discovery and structure-activity relationship of quinuclidine benzamides as agonists of alpha7 nicotinic acetylcholine receptors. , 2005, Journal of medicinal chemistry.
[51] P. Aristoff,et al. Synthesis of benzopyran prostaglandins, potent stable prostacyclin analogs, via an intramolecular mitsunobu reaction , 1985 .
[52] M. Dart,et al. Design of ligands for the nicotinic acetylcholine receptors: the quest for selectivity. , 2004, Current topics in medicinal chemistry.
[53] C. Swain,et al. Novel 5-HT3 antagonists. Indole oxadiazoles. , 1991, Journal of medicinal chemistry.
[54] R. Hurst,et al. The Selective α7 Nicotinic Acetylcholine Receptor Agonist PNU-282987 [N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide Hydrochloride] Enhances GABAergic Synaptic Activity in Brain Slices and Restores Auditory Gating Deficits in Anesthetized Rats , 2005, Journal of Pharmacology and Experimental Therapeutics.
[55] T. Hirata,et al. Aminothiazolylglycyl derivatives of carbacephem antibiotics. II. Synthesis and antibacterial activity of novel aminothiazolyl cephem compounds with hydroxypyridone moiety. , 1987, The Journal of antibiotics.
[56] S. Singh,et al. Efficient synthesis of (±)-N-BOC-exo-2-(methoxycarbonyl)-7-Azabicyclo[2.2.1]heptane, a versatile intermediate for the synthesis of epibatidine and epiboxidine , 1997 .
[57] G. Dondio,et al. Selective kappa-opioid agonists: synthesis and structure-activity relationships of piperidines incorporating on oxo-containing acyl group. , 1994, Journal of medicinal chemistry.
[58] T. Liljefors,et al. Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations. , 2005, Journal of medicinal chemistry.
[59] C M Grill,et al. Closed-loop recycling with periodic intra-profile injection: a new binary preparative chromatographic technique. , 1998, Journal of chromatography. A.
[60] M. Picciotto,et al. Nicotinic Receptors in the Brain: Links between Molecular Biology and Behavior , 2000, Neuropsychopharmacology.
[61] P. Thadeio,et al. Tandem Michael addition and azanorbornane substance-P antagonists , 1997 .